SCHEMBL2117595

SCHEMBL2117595

CN(C)CCc1cnc(Nc2c(F)cccc2F)nc1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.47
CDK9 P50750 3/20 0.45
CCNT1 O60563 2/20 0.45
CDK2 P24941 2/20 0.39
CCNA2 P20248 1/20 0.39
CCNA1 P78396 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HTR2B P41595 1/20 0.39
AOC3 Q16853 1/20 0.38
NOS1 P29475 2/20 0.37
NOS3 P29474 1/20 0.37
NOS2 P35228 1/20 0.37
JAK1 P23458 5/20 0.36
JAK3 P52333 5/20 0.36
JAK2 O60674 3/20 0.36
SYK P43405 2/20 0.35
TYK2 P29597 3/20 0.34
CCNE1 P24864 1/20 0.34
CDK1 P06493 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2112548 0.93 CDK9 (0.44) TAAR1CDK9CCNT1CDK2CCNA2
SCHEMBL2114137 0.92 CDK9 (0.43) TAAR1CDK9CCNT1CDK2CCNA2
SCHEMBL2113279 0.87 TAAR1 (0.43) TAAR1CDK9CCNT1CDK2CCNA2
SCHEMBL2114796 0.86 TAAR1 (0.49) TAAR1CDK2CCNA2CCNA1AOC3
SCHEMBL2115272 0.86 TNK2 (0.42) TAAR1HTR2AJAK1JAK3TYK2
SCHEMBL2113337 0.85 TNK2 (0.44) TAAR1AOC3CDK1KDR
SCHEMBL5527904 0.83 CDK9 (0.36) CDK9CCNT1CDK2CCNA2CCNA1
SCHEMBL2113629 0.82 KMT2A (0.46) TAAR1CDK9CCNT1CDK2SYK
SCHEMBL2113390 0.81 NPC1 (0.52) TAAR1CDK9CCNT1CDK2SYK
SCHEMBL2113372 0.80 NOS1 (0.37) TAAR1CDK9CCNT1NOS1NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158641-B2 2-anilino-4-aminoalkyleneaminopyrimidines BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-17 US disclosed
US-20090181995-A1 2-ANILINO-4-AMINOALKYLENEAMINOPYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-07-16 US disclosed
US-20070293525-A1 2-ANILINO-4-AMINOALKYLENEAMINOPYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293525-A1 2-ANILINO-4-AMINOALKYLENEAMINOPYRIMIDINES PRKCA, PRKCH, PRKCG TAAR1 3765/4885CDK9 267/4885CCNT1 935/4885
US-20090181995-A1 2-ANILINO-4-AMINOALKYLENEAMINOPYRIMIDINES PRKCA, PRKCH, PRKCG TAAR1 3765/4885CDK9 267/4885CCNT1 935/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.